Financials
- Market Capitalization 107.42 M
- Employee 29
- Founded 1998
- CEO N/A
- Website www.oncolyticsbiotech.com
- Headquarter Nevada, United States
- FIGI BBG000DVS826
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3918 | ALDX Aldeyra Therapeutics, Inc. - Common Stock | 1.94 USD | +0.52% | -13.00% | +7.18% | -61.58% | 117.02 M USD | ||
| 3919 | COYA Coya Therapeutics, Inc. - Common Stock | 4.88 USD | +0.62% | -15.13% | +2.09% | -20.39% | 114.47 M USD | ||
| 3950 | ANIX Anixa Biosciences, Inc. - Common Stock | 3.19 USD | +4.25% | +7.77% | +24.12% | -0.93% | 108.53 M USD | ||
| 3953 | BDTX Black Diamond Therapeutics, Inc. - Common Stock | 1.86 USD | -2.11% | -10.58% | +3.33% | -36.95% | 106.58 M USD |
Frequently asked questions about Oncolytics Biotech Inc. - Common Stock
What is the Oncolytics Biotech Inc. - Common Stock stock price today?
The current price of Oncolytics Biotech Inc. - Common Stock (ONCY) is 0.9. Over the past 24 hours, the stock has changed by -3.23%. Follow the ONCY chart for real-time price dynamics.
What is the stock ticker of Oncolytics Biotech Inc. - Common Stock?
Oncolytics Biotech Inc. - Common Stock trades under the ticker ONCY. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Oncolytics Biotech Inc. - Common Stock stock going up?
ONCY has changed by +4.65% over the last week, +9.76% over the last month, and -25.00% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Oncolytics Biotech Inc. - Common Stock net income for the last quarter?
Oncolytics Biotech Inc. - Common Stock reported net income of -9.24 M for the last quarter. The previous quarter showed -23.67 M, which means net income changed by +60.95%.
How many employees does Oncolytics Biotech Inc. - Common Stock have?
As of the latest available data, Oncolytics Biotech Inc. - Common Stock has 29 employees. Workforce size can provide additional context about the company's scale and operations.
What is Oncolytics Biotech Inc. - Common Stock EBITDA?
Oncolytics Biotech Inc. - Common Stock EBITDA is -9.27 M, and its EBITDA margin is 154.52 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Oncolytics Biotech Inc. - Common Stock stock?
You can buy Oncolytics Biotech Inc. - Common Stock (ONCY) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Oncolytics Biotech Inc. - Common Stock stock?
Investing in Oncolytics Biotech Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ONCY chart and related analysis on metatrader.com as part of your research.